ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Persson, G
Right arrow Articles by Stahl, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Persson, G
Right arrow Articles by Stahl, E
Eur Respir J 1988; 1: 681-684
Copyright © ERS Journals Ltd 1988

Clinical Trial

A new multiple dose powder inhaler, (Turbuhaler), compared with a pressurized inhaler in a study of terbutaline in asthmatics

G Persson, E Gruvstad, and E Stahl

Twelve adult asthmatic patients participated in an open, randomized, cross-over comparison between cumulatively increasing doses of terbutaline sulphate administered via the multiple dose powder inhaler (Turbuhaler) or via a pressurized inhaler. Turbuhaler and the pressurized inhaler showed equipotency both with respect to bronchodilatation and side effects. Both treatments produced a significant increase in pulmonary function measurements, forced expiratory volume in one second (FEV1) and forced vital capacity (FVC). No increase in pulse rate was seen with either treatment but there was an increase in tremor at higher doses with both treatments. Inhalation of beta-agonists via Turbuhaler seems to be an effective way of treating asthma.


This article has been cited by other articles:


Home page
 ChestHome page
M. B. Dolovich, R. C. Ahrens, D. R. Hess, P. Anderson, R. Dhand, J. L. Rau, G. C. Smaldone, and G. Guyatt
Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology
Chest, January 1, 2005; 127(1): 335 - 371.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
S Drblik, G Lapierre, R Thivierge, J Turgeon, P Gaudreault, B Cummins-McManus, I Verdy, J Haddon, J Lee, and S Spier
Comparative efficacy of terbutaline sulphate delivered by Turbuhaler dry powder inhaler or pressurised metered dose inhaler with Nebuhaler spacer in children during an acute asthmatic episode
Arch. Dis. Child., April 1, 2003; 88(4): 319 - 323.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
F. S F Ram, J. Wright, D. Brocklebank, and J. E S White
Systematic review of clinical effectiveness of pressurised metered dose inhalers versus other hand held inhaler devices for delivering beta 2 agonists bronchodilators in asthma
BMJ, October 20, 2001; 323(7318): 901 - 901.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. FISHWICK, L. BRADSHAW, C. MACDONALD, R. BEASLEY, D. GASH, T. BENGTSSON, E. BONDESSON, and L. BORGSTRÖM
Cumulative and Single-dose Design to Assess the Bronchodilator Effects of {beta}2-Agonists in Individuals with Asthma
Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 474 - 477.
[Abstract] [Full Text]

Home page
 ThoraxHome page
D A Hughes, A Woodcock, and T Walley
Review of therapeutically equivalent alternatives to short acting beta 2 adrenoceptor agonists delivered via chlorofluorocarbon-containing inhalers
Thorax, December 1, 1999; 54(12): 1087 - 1092.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1988 by the European Respiratory Society.